The role of 18FDG PET/CT in the management of colorectal liver metastases

HPB

Volumn 14, Issue 1, 2012, Pages 20-25

  Engledow, Alec H ^a   Skipworth, James R A ^a,b   Pakzad, Farrokh ^a   Imber, Charles ^b   Ell, Peter J ^a   Groves, Ashley M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Colorectal metastases; Liver; Liver resection

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL EXAMINATION; COLORECTAL CANCER; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGING SYSTEM; LIVER METASTASIS; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; RISK; SCORING SYSTEM; WHOLE BODY CT; WHOLE BODY PET; COLORECTAL TUMOR; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; FOLLOW UP; LIVER TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RADIOGRAPHY; REPRODUCIBILITY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; COLORECTAL NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; FLUORODEOXYGLUCOSE F18; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 83555175979     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2011.00378.x     Document Type: Article

References (41)

1. CRUK (2010) Liver surgery leads to 'remarkable' boost for bowel cancer survival: National Cancer Intelligence Network Press Release. http://info.cancerresearchuk.org/news/archive/pressrelease/2010-06-02- liversurgery-boost-bowel-survival [Accessed04November2011].
2. Faivre J, Manfredi S, Bouvier AM,. (2003) [Epidemiology of colorectal cancer liver metastases]. Bull Acad Natl Med 187: 815-822; discussion 822-823.
3. Simmonds PC, Primrose JN, Colquitt JL, Garden OJ, Poston GJ, Rees M,. (2006) Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer 94: 982-999.
4. Rees M, Tekkis PP, Welsh FK, O'Rourke T, John TG,. (2008) Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 247: 125-135.
5. Adam R, Wicherts DA, de Haas RJ, Ciacio O, Lévi F, Paule B, et al,. (2009) Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? J Clin Oncol 27: 1829-1835.
6. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J, et al,. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55 (Suppl 3): iii1-iii8. (Pubitemid 44085662)
7. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al,. (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239: 818-825; discussion 825-827.
8. Nagashima I, Takada T, Matsuda K, Adachi M, Nagawa H, Muto Tand Okinaga K,. (2004) A new scoring system to classify patients with colorectal liver metastases: proposal of criteria to select candidates for hepatic resection. J Hepatobiliary Pancreat Surg 11: 79-83. (Pubitemid 38678820)
9. Nordlinger B, Guiguet M, Vaillant JC, Balladur P, Boudjema K, Bachellier P, et al,. (1996) Surgical resection of colorectal carcinoma metastases to the liver. A prognostic scoring system to improve case selection, based on 1568 patients. Association Francaise de Chirurgie. Cancer 77: 1254-1262. (Pubitemid 26102322)
10. Tomlinson JS, Jarnagin WR, DeMatteo RP, Fong Y, Kornprat P, Gonen M, et al,. (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25: 4575-4580. (Pubitemid 350035315)
11. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH,. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318; discussion 318-321.
12. Minagawa M, Makuuchi M, Torzilli G, Takayama T, Kawasaki S, Kosuge T, et al,. (2000) Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg 231: 487-499. (Pubitemid 30185854)
13. Carpizo DR, D'Angelica M,. (2009) Liver resection for metastatic colorectal cancer in patients with concurrent extrahepatic disease: results in 127 patients treated at a single center. Ann Surg Oncol 16: 2138-2146.
14. Adam R, Pascal G, Azoulay D, Tanaka K, Castaing D, Bismuth H,. (2003) Liver resection for colorectal metastases: the third hepatectomy. Ann Surg 238: 871-883; discussion 883-884.
15. Minagawa M, Yamamoto J, Kosuge T, Matsuyama Y, Miyagawa S, Makuuchi M,. (2007) Simplified staging system for predicting the prognosis of patients with resectable liver metastasis: development and validation. Arch Surg 142: 269-276; discussion 277. (Pubitemid 46457054)
16. Robinson PJ,. (2000) Imaging liver metastases: current limitations and future prospects. Br J Radiol 73: 234-241. (Pubitemid 30192793)
17. Bipat S, van Leeuwen MS, Comans EF, Pijl ME, Bossuyt PM, Zwinderman AH, et al,. (2005) Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology 237: 123-131. (Pubitemid 41346155)
18. Papathanassiou D, Bruna-Muraille C, Liehn JC, Nguyen TD, Curé H,. (2009) Positron Emission Tomography in oncology: present and future of PET and PET/CT. Crit Rev Oncol Hematol 72: 239-254.
19. Cohade C, Osman M, Leal J, Wahl RL,. (2003) Direct comparison of (18) F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44: 1797-1803. (Pubitemid 39663312)
20. Engledow AH, Skipworth JR, Blackman G, Groves A, Bomanji J, Warren SJ, et al,. (2011) The role of 18fluoro-deoxy glucose combined position emission and computed tomography in the clinical management of anal squamous cell carcinoma. Colorectal Dis 13: 532-537.
21. Tann M, Sandrasegaran K, Jennings SG, Skandarajah A, McHenry L, Schmidt CM,. (2007) Positron-emission tomography and computed tomography of cystic pancreatic masses. Clin Radiol 62: 745-751. (Pubitemid 46971644)
22. Goerres GW, Kamel E, Seifert B, Burger C, Buck A, Hany TF, et al,. (2002) Accuracy of image coregistration of pulmonary lesions in patients with non-small cell lung cancer using an integrated PET/CT system. J Nucl Med 43: 1469-1475. (Pubitemid 35285872)
23. Warburg O,. (1956) On the origin of cancer cells. Science 123: 309-314.
24. Kinkel K, Lu Y, Both M, Warren RS, Thoeni RF,. (2002) Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224: 748-756. (Pubitemid 34919808)
25. Arulampalam T, Costa D, Visvikis D, Boulos P, Taylor I, Ell P,. (2001) The impact of FDG-PET on the management algorithm for recurrent colorectal cancer. Eur J Nucl Med 28: 1758-1765. (Pubitemid 33141239)
26. Arulampalam TH, Francis DL, Visvikis D, Taylor I, Ell PJ,. (2004) FDG-PET for the pre-operative evaluation of colorectal liver metastases. Eur J Surg Oncol 30: 286-291. (Pubitemid 38425646)
27. Floriani II, Torri V, Rulli E, Garavaglia D, Compagnoni A, Salvolini L, et al,. (2010) Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: a systematic review and meta-analysis. J Magn Reson Imaging 31: 19-31.
28. Wiering B, Krabbe PF, Jager GJ, Oyen WJ, Ruers TJ,. (2005) The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases. Cancer 104: 2658-2670. (Pubitemid 41798276)
29. Metser U, You J, McSweeney S, Freeman M, Hendler A,. (2010) Assessment of tumor recurrence in patients with colorectal cancer and elevated carcinoembryonic antigen level: FDG PET/CT versus contrast-enhanced 64-MDCT of the chest and abdomen. AJR Am J Roentgenol 194: 766-771.
30. Grassetto G, Fornasiero A, Bonciarelli G, Banti E, Rampin L, Marzola MC, et al,. (2010) Additional value of FDG-PET/CT in management of 'solitary' liver metastases: preliminary results of a prospective multicenter study. Mol Imaging Biol 12: 139-144.
31. Chua SC, Groves AM, Kayani I, Menezes L, Gacinovic S, Du Y, et al,. (2007) The impact of 18F-FDG PET/CT in patients with liver metastases. Eur J Nucl Med Mol Imaging 34: 1906-1914. (Pubitemid 350212127)
32. Wiering B, Krabbe PF, Dekker HM, Oyen WJ, Ruers TJ,. (2007) The role of FDG-PET in the selection of patients with colorectal liver metastases. Ann Surg Oncol 14: 771-779. (Pubitemid 46175326)
33. Ruers TJ, Wiering B, van der Sijp JR, Roumen RM, de Jong KP, Comans EF, et al,. (2009) Improved selection of patients for hepatic surgery of colorectal liver metastases with (18)F-FDG PET: a randomized study. J Nucl Med 50: 1036-1041.
34. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al,. (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240: 644-657; discussion 657-658.
35. Sahajpal A, Vollmer CM Jr, Dixon E, Chan EK, Wei A, Cattral MS, et al,. (2007) Chemotherapy for colorectal cancer prior to liver resection for colorectal cancer hepatic metastases does not adversely affect peri-operative outcomes. J Surg Oncol 95: 22-27. (Pubitemid 46122713)
36. Scoggins CR, Campbell ML, Landry CS, Slomiany BA, Woodall CE, McMasters KM, et al,. (2009) Preoperative chemotherapy does not increase morbidity or mortality of hepatic resection for colorectal cancer metastases. Ann Surg Oncol 16: 35-41.
37. Vriens D, van Laarhoven HW, van Asten JJ, Krabbe PF, Visser EP, Heerschap A,. (2009) Chemotherapy response monitoring of colorectal liver metastases by dynamic Gd-DTPA-enhanced MRI perfusion parameters and 18F-FDG PET metabolic rate. J Nucl Med 50: 1777-1784.
38. CancerResearchUK (2010) PET-CT scan [WWW document]. URL http://www.cancerhelp.org.uk/about-cancer/tests/petct-scan#uk [Accessed 4 November 2011].
39. Hahn S, Heusner T, Zhou X, Zhan Y, Peng Z, Hamami M, et al,. (2010) Computer-aided detection (CAD) and assessment of malignant lesions in the liver and lung using a novel PET/CT software tool: initial results. Rofo 182: 243-247.
40. Donati OF, Hany TF, Reiner CS, von Schulthess GK, Marincek B, Seifert B, et al,. (2010) Value of retrospective fusion of PET and MR images in detection of hepatic metastases: comparison with 18F-FDG PET/CT and Gd-EOB-DTPA-enhanced MRI. J Nucl Med 51: 692-699.
41. Welsh FK, Tekkis PP, John TG, Rees M,. (2008) Predictive models in colorectal liver metastases-can we personalize treatment and outcome? Dig Surg 25: 406-412.